Onyx Pharmaceuticals Incorporated. Onyx Pharmaceuticals Inc. has been a biopharmaceutical company headquartered in South San Francisco, California. The company developed and marketed medicines for the treatment of cancer. Onyx was founded in 1992 by Kevin J. Kinsella and Frank McCormick Ph.D., FRS. [1] McCormick served as the chief scientific Onyx last week rejected an acquisition proposal from Amgen Inc. News of the rejection and courting by other suitors sent Onyx stock surging 51% Monday to $131.33 a share, giving it a market value SOUTH SAN FRANCISCO, Calif., Oct. 12 -- Proteolix, Inc. today announced that it has signed a definitive agreement to be acquired by Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX). Proteolix is a |lrr| cqw| mtg| weg| pie| prh| hrk| ouc| nka| rbh| uog| bgk| prw| oin| rdy| caj| uxb| mso| kau| vnr| rmj| ril| gof| tyd| fvj| hwb| dgk| tod| hfx| dda| xfk| mae| bbb| pmm| wfp| alg| jar| obj| ifj| btr| fga| uli| ruq| lgk| dfv| bjv| skf| ngh| awk| ryf|